Skip to content
Research Article Open access CC BY 4.0

Insulin Mediated Lipohypertrophy

Manda Anusha, Jannapala Anusha, Adiba Nousheen, Enara Bawani, Sangareddy Jayanth Kumar

Asian Journal of Research and Reports in Endocrinology · pp. 87–91 · Published 1 Jul 2023

Abstract

Insulin is used to treat diabetes Type I and II. This article explains how a lipohypertrophy is caused by the insulin and explains the precautions that should be taken during the administration of insulin. Lipohypertrophy (LH) is a typical side effect of insulin therapy in subcutaneous tissue. Several injections at the same place result in this problem. A potential underlying mechanism of lipohypertrophy is the production of insulin antibodies. Recognizing and effectively managing these problems are crucial. In order to detect mild forms of lipohypertrophy, every patient should have their lips thoroughly evaluated for the condition during a diabetes clinic evaluation. The best current preventative and therapeutic approaches for lipohypertrophy are non-reuse of needles and rotation of injection sites with each injection. Education for both doctors and patients on recognising and treating lipohypertrophy is advisable.

Diabetes insulin lipohypertrophy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.